Long-term strategy for cellular therapy
The challenge
A large oncology company was looking to capitalize on early advantages in the cell therapy market. The organization engaged Putnam to support the development of 10-year strategy, focused on continuous innovation across all aspects of the business – from discovering and in-licensing novel technologies, to clinical development optimization, manufacturing improvements, and supply chain enhancements.
Our solution
Our team critically assessed the evolving market landscape, identifying key growth drivers, such as expanded indications with existing products and technologies, launches of new products with proven technologies and “bold bet” technologies, and projecting revenues. We also collaborated with the client to determine key pillars of successful strategy, grounded in detailed assessment of novel emerging technologies’ commercial potential.
The results
We were able to deliver and reach consensus on a sound 10-year company strategy, starting with synthesizing team discussions into an executive summary for c-suite review with specific needs that would need to be addressed and associated budget requests. We put emphasis on a continuous innovation cycle informed by strategic focus, expansion, and smart bets.
Jump to a slide with the slide dots.
Patient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read moreData Strategy Development
Future-proofed data strategy with Putnam: gaps identified, vendors vetted, leading to a first US multi-source tokenized DB.
Read more